Clinical Trials on Iliac; Thrombosis in Hong Kong

Total 69 results

Abbott Medical Devices

Recruiting

JETi Hong Kong Post Market Study (PMS)

Peripheral Artery Thrombosis | Peripheral Venous Thrombosis

Hong Kong
Cook Group Incorporated

Terminated

Zenith(R) Connection Endovascular Covered Stent Clinical Study

Aorto-iliac Aneurysms | Iliac Aneurysms

Hong Kong, United Kingdom, Germany
Queen Mary Hospital, Hong Kong

Recruiting

The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients (THROM-CRIT)

Central Line Complication | Thrombosis, Venous

Hong Kong
The University of Hong Kong

Unknown

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

Hong Kong
Prof. Stephen Lee

Completed

OCT Evaluation of Healing of COMBO Stent (EGO-COMBO)

Coronary Thrombosis | Coronary Restenosis

Hong Kong
Chinese University of Hong Kong

Recruiting

Ex Vivo Test of New Stroke Treatment Using Magnetic Nanorobots

Thrombosis

Hong Kong
Humanity & Health Medical Group Limited

Completed

Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura

Immune Thrombocytopenia

Hong Kong
Chinese University of Hong Kong

Not yet recruiting

Venous Thromboembolism (VTE) Knowledge

Thromboembolism

Hong Kong
Tuen Mun Hospital
AstraZeneca

Completed

Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus | Atherosclerosis | Thromboembolism

Hong Kong
The University of Hong Kong

Recruiting

Translational Immunodiagnostics in Stroke (TrImS) (TrImS)

Atrial Fibrillation | Acute Ischemic Stroke | Transient Ischemic Attacks | Cardioembolic Stroke | Large-Artery Atherosclerosis (Embolus/Thrombosis) | Haemorrhagic Stroke | Small Vessel Disease | Stroke of Other Determined Etiology | Stroke of Undetermined Etiology | Stroke of Anterior Cerebral Artery | Stroke... and other conditions

China
Chinese University of Hong Kong

Recruiting

DOAC in Chinese Patients With Atrial Fibrillation (DOAC-REAL)

Stroke | Brain Diseases | Atrial Fibrillation | Venous Thromboembolism | Stroke, Acute | Major Adverse Cardiovascular Event | Arterial Thromboembolism

Hong Kong
Chinese University of Hong Kong

Recruiting

Impact of COVID-19 Vaccines on Cerebrovascular Health

Stroke | Brain Diseases | Brain Ischemia | Dementia | Alzheimer Disease | Venous Thromboembolism | Stroke, Ischemic | Stroke, Acute | Major Adverse Cardiovascular Event | Arterial Thromboembolism

Hong Kong
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea; Daiichi Sankyo Korea Co., Ltd.

Completed

Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement (ADAPT-TAVR)

Aortic Valve Stenosis

Taiwan, Hong Kong, Korea, Republic of
Chinese University of Hong Kong

Recruiting

Safety and Efficacy of Fecal Microbiota Transplantation

Alcohol Dependence | Multiple Sclerosis | Obesity | Diabetes Mellitus | Hepatic Encephalopathy | Irritable Bowel Syndrome | Constipation | Celiac Disease | Crohn Disease | Ulcerative Colitis | Liver Disease | Idiopathic Thrombocytopenic Purpura | Clostridium Difficile Infection | Alopecia | Autism | Multiple Organ Dysfunction... and other conditions

Hong Kong
Cook Group Incorporated

Completed

Zenith(R) Low Profile AAA Endovascular Graft Clinical Study

Abdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac Aneurysms

United States, China, Germany, Sweden, Russian Federation
University Hospital Inselspital, Berne

Completed

Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis (INVEST)

Drug-Eluting Stents | Coronary Thrombosis | Tomography, Optical Coherence

Austria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
Allergan

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Macular Edema | Retinal Vein Occlusion

United States, Poland, United Kingdom, Colombia, Spain, Korea, Republic of, Singapore, Brazil, New Zealand, Hong Kong, Italy, Canada, India
Qianfoshan Hospital

Not yet recruiting

Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients

Venous Thromboembolic Disease

China
Ripple Therapeutics Pty Ltd
Novotech (Australia) Pty Limited

Active, not recruiting

Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy

Diabetic Macular Oedema | Retinal Vein Occlusion With Macular Oedema

Australia, New Zealand, Hong Kong, Canada
MemorialCare Health System

Completed

Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis

Obesity | Pregnancy | Venous Thromboembolism | Obesity, Morbid | Pulmonary Embolism | Complications; Cesarean Section | Postpartum Deep Phlebothrombosis

United States
Hanscom, Thomas, M.D.
Genentech, Inc.

Completed

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab (RAVEN)

Central Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein Occlusion

United States
Novartis Pharmaceuticals

Completed

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO) (Camellia)

Central Retinal Vein Occlusion

China, Taiwan, Hong Kong, Philippines, Vietnam, Indonesia, India
Novartis Pharmaceuticals

Completed

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) (Blossom)

Macular Edema Secondary to Branch Retinal Vein Occlusion

China, Taiwan, Hong Kong, Philippines, Vietnam, Indonesia
Omeros Corporation

Completed

Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies

Thrombotic Microangiopathies

United States, Belgium, Bulgaria, Hong Kong, Italy, Lithuania, Malaysia, New Zealand, Poland, Singapore, Taiwan, Thailand
Bayer
Janssen Research & Development, LLC

Completed

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty (XAMOS)

Venous Thromboembolism

Switzerland, China, Slovakia, France, Germany, Hungary, Korea, Republic of, Singapore, South Africa, Spain, Sweden, Philippines, Australia, Austria, Colombia, Czech Republic, Estonia, Hong Kong, Italy, Latvia, Lebanon, Lithuania, Macedonia... and more
Brigham and Women's Hospital
Sanofi

Completed

Discharge ALERT: Quality Improvement Initiative (Discharge)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Prevention | Prophylaxis

United States
Population Health Research Institute

Completed

PeriOperative ISchemic Evaluation-3 Trial (POISE-3)

Venous Thrombosis | Arterial Thrombosis | Perioperative Bleeding

Spain, United States, Germany, Hong Kong, Australia, New Zealand, Canada, United Kingdom, Austria, Belgium, Malaysia, Brazil, Netherlands, China, Pakistan, Russian Federation, France, Chile, Denmark, India, Italy, Poland, South Africa
Brigham and Women's Hospital
Sanofi

Completed

Multi-Center Human Alert Trial to Prevent DVT and PE

Cancer | Surgery | Deep Vein Thrombosis | Pulmonary Embolism

United States
GlaxoSmithKline

Completed

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

Purpura, Thrombocytopaenic, Idiopathic

Thailand, Korea, Republic of, United Kingdom, New Zealand, Germany, Greece, Hong Kong, Pakistan, Poland, Romania, Russian Federation, Slovenia, Taiwan
Inquis Medical, Inc.

Recruiting

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Cardiovascular Diseases | Vascular Diseases | Respiratory Tract Diseases | Lung Diseases | Embolism | Embolism and Thrombosis | Pulmonary Embolism

United States
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

France, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
Outlook Therapeutics, Inc.

Completed

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Age-related Macular Degeneration | Diabetic Macular Edema | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | BRVO - Branch Retinal Vein Occlusion

United States
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion (BALATON)

Macular Edema | Branch Retinal Vein Occlusion

United States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
Pfizer

Completed

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Venous Thrombosis

Australia, United States, Spain, Czech Republic, Portugal, Canada, South Africa, Italy, Colombia, Poland, France, Chile, Russian Federation, Denmark, United Kingdom, Slovakia
Bristol-Myers Squibb

Completed

Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness (ADOPT)

Venous Thrombosis | Pulmonary Embolism

Argentina, Australia, France, India, Korea, Republic of, United Kingdom, United States, Spain, Mexico, Colombia, Austria, Denmark, Canada, Germany, Israel, Peru, Singapore, Sweden, Poland, Belgium, Hungary, Italy, Russian Federation, ... and more
GlaxoSmithKline

Completed

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Purpura, Thrombocytopaenic, Idiopathic

Italy, Germany, Hong Kong, Korea, Republic of, United States, Pakistan, Russian Federation, India, Czech Republic, Hungary, France
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study

Venous Thrombosis

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, United States, New Zealand, Poland, India, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Brazil, Denmark, Germany, Norw... and more
Novartis Pharmaceuticals

Terminated

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion (RAPTOR)

Branch Retinal Vein Occlusion

China, Austria, Czechia, Russian Federation, Taiwan, United Kingdom, Canada, Japan, United States, France, Israel, Germany, Italy, Hong Kong, Spain, Denmark, Slovakia, Puerto Rico, Switzerland
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Venous Thromboembolism

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, New Zealand, Poland, India, United States, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Taiwan, Brazil, Denmark, German... and more
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion (COMINO)

Central Retinal Vein Occlusion | Macular Edema | Hemiretinal Vein Occlusion

United States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Germany, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
Bristol-Myers Squibb
Pfizer

Completed

Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Venous Thrombosis

Argentina, Australia, Canada, China, Czech Republic, India, Italy, Korea, Republic of, United States, Spain, France, Brazil, Russian Federation, Mexico, Austria, Denmark, Germany, Hungary, Israel, Portugal, Romania, Singapore, Norway, Chil... and more
Bristol-Myers Squibb
Pfizer

Completed

Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Venous Thrombosis

Australia, Czech Republic, India, Italy, Korea, Republic of, Mexico, United Kingdom, United States, Hong Kong, Spain, France, Argentina, Brazil, Russian Federation, Austria, Denmark, Germany, Israel, Portugal, Romania, Singapore, ... and more
Bristol-Myers Squibb

Completed

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Venous Thrombosis | Pulmonary Embolism

United States, Argentina, Canada, Mexico, Puerto Rico, Israel, Australia, Poland, Denmark
Beijing Chao Yang Hospital
Ministry of Science and Technology of the People´s Republic of China

Unknown

Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD

Pulmonary Embolism | Pulmonary Thromboembolisms

China
Phramongkutklao College of Medicine and Hospital
Chulalongkorn University; Chiang Mai University; Thammasat University; Police General... and other collaborators

Unknown

Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery

Open Fracture of Hip

Thailand
Takeda

Completed

Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement

Venous Thromboembolism

United States, Canada
Bayer
Janssen Research & Development, LLC

Completed

EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis (EINSTEIN Jr)

Venous Thromboembolism

Belgium, China, Hong Kong, United States, Switzerland, Spain, Russian Federation, Singapore, Canada, Germany, Netherlands, United Kingdom, Austria, Brazil, Israel, Italy, Mexico, Turkey, France, Australia, Finland, Hungary, Japan, Arg... and more
Sanofi

Completed

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy (SAVE-ONCO)

Cancer | Venous Thromboembolism

France, Spain, Hong Kong, Austria, Canada, Lithuania, South Africa, Sweden, Romania, United States, Greece, Korea, Republic of, Ukraine, Argentina, Australia, Belarus, Belgium, Brazil, Bulgaria, Chile, China, Colombia, Croatia, Czech... and more
GlaxoSmithKline

Completed

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. (PETIT2)

Idiopathic Thrombocytopenic Purpura

Thailand, Israel, Poland, Russian Federation, Spain, Germany, United Kingdom, Taiwan, Hong Kong, Czech Republic, Italy, United States, Argentina
Penumbra Inc.

Recruiting

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

Pulmonary Embolism

United States, Spain, Netherlands, United Kingdom, Portugal, Italy, Poland

Clinical Trials on Iliac; Thrombosis in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations